# Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)

> **NCT00188578** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 12 (actual)

## Conditions studied

- Cervix Neoplasms
- Uterine Neoplasms
- Vaginal Neoplasms

## Interventions

- **PROCEDURE:** Intensity Modulated Radiation Therapy Boost

## Key facts

- **NCT ID:** NCT00188578
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188578, "Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00188578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*